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In Brief
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virus-infected targets are unclear.
Hickman and colleagues show that
CXCR3 expression on CD8+ T cells
enhances their ability to locate infected
cells in the skin and thus maximizes viral
clearance.
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CD8+ T cells play a critical role in limiting peripheral
virus replication, yet how they locate virus-infected
cells within tissues is unknown. Here, we have exam-
ined the environmental signals that CD8+ T cells use
to localize and eliminate virus-infected skin cells. Epi-
cutaneous vaccinia virus (VV) infection, mimicking
human smallpox vaccination, greatly increased
expression of theCXCR3 chemokine receptor ligands
CXCL9 and CXCL10 in VV-infected skin. Despite
normal T cell numbers in the skin, Cxcr3/ mice ex-
hibited dramatically impaired CD8+-T-cell-dependent
virus clearance. Intravital microscopy revealed that
Cxcr3/ T cells were markedly deficient in locating,
engaging, and killing virus-infected cells. Further,
transfer of wild-type CD8+ T cells restored viral clear-
ance inCxcr3/animals.Thesefindingsdemonstrate
a function forCXCR3 inenhancing the ability of tissue-
localized CD8+ T cells to locate virus-infected cells
and thereby exert anti-viral effector functions.
INTRODUCTION
Viral infections of vertebrates typically begin in mucosal surfaces
or the skin, where virions can be introduced by insect bites or
directly into cuts or abrasions. Locally released virions often
infect adjacent cells but can potentially spread distally via the
blood or lymphatics. Viral proteins are delivered to draining
lymph nodes (DLNs) as free virions or sub-virion forms or by
antigen-presenting cells (APCs) that either are infected with the
virus or cross-present viral proteins that they have acquired
from other cells. Within DLNs, naive CD8+ T cells survey infected
or cross-presenting APCs. Cognate T cells become activated,
proliferate, and traffic to peripheral infected tissues to resolve vi-
rus infection through a variety of effector mechanisms, including
lysing infected cells and releasing antiviral cytokines (Gordon
et al., 2011; Liu et al., 2010; Mota et al., 2011).
Recent intravital multiphoton microscopy (MPM) studies into
the in vivo function of effector CD8+ T cells have focused on prim-
ing in the DLNs, providing great insight into the events leading to
naive T cell activation (for reviews, see Henrickson and von An-524 Immunity 42, 524–537, March 17, 2015 ª2015 Elsevier Inc.drian, 2007; Hickman et al., 2011a; Mueller and Hickman,
2010). Less is known about howCD8+ T cells exert their anti-viral
functions during active primary infections in the tissue. Using a
vaccinia virus (VV) mouse ear-infection model, we defined a cen-
tral role for CD8+ T cells in clearing mobile virus-infected inflam-
matorymonocytes (Hickmanet al., 2013). Althoughadept at elim-
inating this subset of infected cells, CD8+ T cells only reluctantly
entered compact foci of VV-infected keratinocytes. Thus, highly
selective interactions coordinate viral clearance in the tissue.
It is currently unclear how antiviral effector CD8+ T cells locate
and further select particular infected cells within a complex tis-
sue environ; however, chemokines often shape cellular move-
ment through a number of mechanisms. Ligation of soluble
chemokine to the cognate receptor leads to integrin activation
essential for the stable adhesion required for transmigration
through inflamed vessels (the role of integrins in interstitial migra-
tion is more varied) (Friedl and Weigelin, 2008; La¨mmermann
et al., 2008; Overstreet et al., 2013). Diffusible chemokine gradi-
ents induce cellular chemotaxis in vitro, whereas in vivo chemo-
kines can also be bound to extracellular matrix components and
displayed on cell surfaces and thereby promote cell-cell interac-
tions (Hsieh et al., 2006; Proudfoot et al., 2003; Rot, 1993).
Chemokine deficiencies lead to enhanced susceptibility to
many viral infections in both mice and humans, indicating an
important role for chemokine-guided migration in the mitigation
of virus-induced pathology (Lim and Murphy, 2011). Although
chemokines clearly aid in the entry of immune effectors into in-
fected tissue, their role after cellular entry in shaping migration
patterns in situ has not been established during viral infection.
Here, we examined the role of chemokines during cytotoxic T
lymphocyte ‘‘hunting’’ of virus-infected cells. Because viruses
can cleverly manipulate gene expression in infected cells, it is
possible that they control chemokine secretion to prevent detec-
tion and thus enhance replication and ultimately host transmis-
sion. We imaged T cell location, movement, and function in
VV-infected skin, defining a role for CXCR3 ligands in CD8+
T cell recognition and killing of virus-infected cells.
RESULTS
Activated T Cells Contact Peripheral Virus-Infected
Cells Lacking Cognate Antigen
We previously reported that after epicutaneous recombinant
(thymidine kinase [TK]) VV inoculation, most infected cells in
Figure 1. CD8+ T Cells Find Virus-Infected Cells that Do Not Express Cognate Ag
(A) Experimental design. A total of 2.5 3 105 OT-I T cells were transferred into wild-type (WT) animals prior to epicutaneous infection with VV-NP-S-eGFP (with
cognate Ag) in one ear and infection with NP-eGFP (no cognate Ag) in the contralateral ear.
(B) OT-I cells per node (left) or ear (right) as determined by flow cytometric analysis. Infection with NP-S-eGFP (green) and NP-eGFP (blue) is shown. The p.i. day is
shown on the x axis. Error bars represent the SEM for n = 3–5 mice per group per time point.
(C) Maximum intensity projections (MIPs) of MPM images of VV-infected ears were taken at the indicated p.i. day (top of images). Dermal collagen (blue), OT-I
CD8+ T cells (red), and virus-infected cells (green) are shown. Top panels show virus expressing SIINFEKL, and bottom panels show virus lacking SIINFEKL.
Higher-magnification images on p.i. day 6 are shown on the far right. Scale bars represent 50 or 30 mm as indicated.
(D) Time-lapse MIP MPM images from p.i. day 5 show contralateral infection as described in (A). White lines indicate paths of selected CD8+ T cells during the
25-min imaging period. Scale bars represent 20 mm. Time (upper right-hand corner) is shown in min.
All experiments were repeated three times with n = 3–5 mice/group. See also Figure S1 and Movie S1.the skin are LY6C+ inflammatory monocytes or keratinocytes
(Hickman et al., 2013). Activated antigen (Ag)-specific CD8+
T cells migrate into the tissue and principally focus on killing in-
fected monocytes rather than keratinocytes (Hickman et al.,
2013). To better understand how CD8+ T cells locate virus-in-
fected cells, we first examined the contribution of cognate Ag
to T cell behavior in VV-infected skin.Twelve hours after adoptively transferring 2.5 3 105 dsRed
OT-I T cell receptor (TCR) transgenic CD8+ T cells (red, specific
for Kb-SIINFEKL) into albino C57BL/6 mice, we inoculated mice
epicutaneously with VV-NP-S-eGFP (which expresses SIINFEKL
fused to a nuclear-targeted fluorescent protein; Hickman et al.,
2011b; Hickman et al., 2008) in one ear and with VV-NP-eGFP
(same construct lacking SIINFEKL) in the other ear (Figure 1A).Immunity 42, 524–537, March 17, 2015 ª2015 Elsevier Inc. 525
Figure 2. CXCR3 Ligands Are Upregulated in VV-Infected Skin
(A) mRNA regulation in VV-infected ears on p.i. day 5 is compared to that in uninfected ears. Black lines indicate means.
(B) a-chemokine mRNA regulation in VV-infected ears on p.i. day 5 is compared to that in uninfected ears. Black lines indicate means.
(C) Cxcl9 (green) and Cxcl10 (blue) mRNA expression in infected skin at the indicated p.i. days (x axis).
(D) mRNA regulation is compared between uninfected (blue dots) and infected (red dots) inflammatory monocytes sorted from day-5 infected ears.
(E) Confocal images taken on p.i. day 5 show frozen tissue sections with VV-NP-S-eGFP (green nuclear staining), CXCL9 (white), OT-I T cells (red), and CD11b
(blue). The middle panel shows higher magnification of the orange dashed square from the left panel. The orange arrow indicates an OT-I CD8+ T cell that is
interacting with VV-infectedCXCL9+CD11b+ cells. In the right panels, the image from themiddle panel is shownwith only one color (channel) for clarity. Scale bars
represent 50 or 5 mm as indicated.
All experiments were repeated three times. For mRNA data, dots represent separate experiments with n = 2–5 mice/group. See also Figures S2 and S3.Initially, we enumerated OT-I CD8+ T cells in ears and DLNs at
post-infection (p.i.) days 1–8, which spanned the infectious pro-
cess from the first few infected cells to complete resolution in
most cases (Figure 1B; Hickman et al., 2013). OT-I CD8+
T cells increased greatly (150–600,000) in the lymph node
(LN) draining the ear infected with VV-NP-S-eGFP; fewer OT-I
cells were recovered from the non-cognate Ag (VV-NP-eGFP)
DLN at each time point. Despite the SIINFEKL-dependent
disparity in T cell numbers in LNs, cognate Ag had little effect
on OT-I T cell numbers in the ear (Figure 1B, right panel). Impor-
tantly, OT-I T cells were not recruited to uninfected ears (Fig-
ure S1). Thus, VV-induced skin inflammation per se is sufficient
to recruit activated T cells in the absence of cognate Ag.
How does cognate Ag affect OT-I CD8+ T cell entry to virus-in-
flamed skin? MPM imaging of ears on p.i. days 5–7 revealed that
Ag was not required for OT-I cells to locate and surround kerati-
nocytic foci of virus replication (Figure 1C) or infected inflamma-
tory monocytes (Figure 1D). Cognate Ag was clearly required,526 Immunity 42, 524–537, March 17, 2015 ª2015 Elsevier Inc.however, for T cells to stably interact with infected monocytes:
in the absence of SIINFEKL, OT-I cells quickly scanned infected
cells and moved on (shown in white tracks and Movie S1).
Together, these data show that T cells enter VV-infected skin
and locate virus-infected cells independently of cognate Ag
expression but require Ag to stably interact with infected cells.
Infected Monocytes Produce CXCR3 Ligands in VV-
Infected Skin
In order to address which factors govern CD8+ T cell interactions
in infected tissue, we performed chemokine- and cytokine-
focused qPCR arrays on mRNA isolated from uninfected or
infected (p.i. day 5) ear skin (Figure 2). Of 34 cytokine and b-che-
mokine genes examined, the four greatest increases were in
interferon-g (Ifng, upregulated 200-fold) and b-chemokines
genes Ccl4, Ccl7, and Ccl20, whose expression increased
20- to 100-fold (Figure 2A, right panel). Even greater changes
were found in the eight a-chemokine genes tested, two of which,
Cxcl9 and Cxcl10, demonstrated >1,000-fold expression in-
creases (Figure 2B). Fine kinetic examination of Cxcl9 and
Cxcl10 expression revealed parallel increases on day 3 (Fig-
ure 2C); Cxcl10 mRNA peaked on day 5 (concurrent with
maximal numbers of infected monocytes; Figure S2), and
Cxcl9 mRNA peaked 2 days later.
We next sorted both infected and uninfected inflammatory
monocytes from VV-infected skin (ears) on p.i. day 5 on the basis
of VV-encoded GFP expression and cell-surface antibody
staining (CD45+Ly6C+CD11b+ cells) and analyzed a-chemokine
mRNA expression (Figure 2D). Compared to uninfected whole-
ear cells (in the absence of infection, the presence of too few
monocytes prevents the isolation of a control population), both
infected and uninfected inflammatory monocytes displayed
increased chemokine mRNA, and infected cells demonstrated
much greater (nearly 5,000-fold) increases. The pattern was
identical to that seen in the whole ear (the sole exception was
that isolated monocytes showed a slight increase in Cxcl1,
whereas the whole-ear sample did not), consistent with inflam-
matory monocytes as a principal source of VV-induced chemo-
kines. Note that the increase in infected versus uninfected
inflammatory monocytes demonstrates that chemokine mRNA
expression was induced by VV infection and is not a general
feature of this cell type in situ or an artifact of their isolation
from the ear.
To confirm chemokine synthesis, we performed flow cytomet-
ric (Figure S3) and microscopic (Figure 2E) analyses of infected
ears. Taken at p.i. day 5, confocal images of frozen sections
of VV-infected ears showed OT-I CD8+ T cells (red) interacting
with VV-infected (green) CD11b+ (blue) cells (inflammatory
monocytes). Notably, many infected cells synthesized CXCL9,
as indicated by staining in white.
Taken together, our findings indicate that Cxcl9 and Cxcl10
mRNAs are highly upregulated in VV-infected skin and that these
chemokines are abundantly expressed by infected inflammatory
monocytes.
VV Infection Is Exacerbated in Cxcr3–/– Mice
To understand the role of CXCL9 and CXCL10 in the recognition
of VV-infected cells in vivo, we infected mice deficient in CXCR3,
the common receptor for these chemokines (Cole et al., 1998;
Mahalingam et al., 1999). On p.i. day 5, we performed confocal
imaging to scan large areas of infected skin for hematopoietic
cells (CD45+ cells [blue] and virus-infected cells [green]; Fig-
ure 3A). As previously described for wild-type (WT) mice, we
identified only a small focus of remaining virus-infected cells
(Figure 3A, upper middle of left panel). In contrast, Cxcr3/
mice infected in parallel exhibited enormous numbers of virus-in-
fected cells throughout the ear (Figure 3A, right panel). Immuno-
histochemical staining of ears for CD11b (white) revealed that
the majority of infected cells were most likely inflammatory
monocytes (Figure 3B).
We next performed flow cytometric analysis of cells from
enzymatically dissociated ears to better identify and enumerate
infected cell populations (Figure 3C). As previously described
(Hickman et al., 2013), at p.i. day 5 WT mice exhibited infiltration
of inflammatory monocytes, many of which were infected (GFP+)
(Figure 3C, top panels). Cellular infiltration was remarkably
similar in Cxcr3/mice on p.i. day 5 in that they showed equiv-alent numbers of inflammatory monocytes (Figures 3C [bottom
panels] and 3D). As in WT mice, a majority of infected cells
were LY6CGint inflammatory monocytes (Figure 3C [far right
panels]). Whereas the total number of inflammatory monocytes
was the same at p.i. day 5, the number on day 6 was higher in
Cxcr3/ mice. Most importantly, infected inflammatory mono-
cytes were 4-fold more numerous in Cxcr3/ mice at p.i.
day 5 (they peaked at 7 3 104 infected monocytes per ear)
and remained elevated until p.i. day 8 (Figure 3E). In parallel,
Cxcr3/ mice demonstrated increased peak VV titers and
most likely delayed complete clearance (Figure 3F).
To determine the cell type responsible for eliminating the
virus-infected inflammatory monocytes, we performed anti-
body-based depletions in WT or Cxcr3/ mice (antibody was
given on p.i. days 4 and 5) and then examined ears for the num-
ber of infected cells remaining on p.i. day 6 (a timewhenWTmice
have mostly eliminated infected cells under normal conditions)
(Figure 3G). As previously reported (Hickman et al., 2013),
depletion of CD8+ T cells (but not natural killer [NK] cells) reduced
clearance in WT mice (Figure 3G, middle blue bars). CD8+ T cell
depletion augmented by 4.5-fold the already higher numbers
of inflammatory monocytes in Cxcr3/ mice than in depleted
WT mice (green bars).
Together, these data demonstrate that CXCR3 deletion delays
CD8+ T cell control of VV-infected inflammatory monocytes,
consistent with an important role for CXCL9 and CXCL10 in con-
trolling local VV infection.
VV-Infected Cxcr3–/– Mice Exhibit Normal T Cell
Activation and Skin Homing
Cxcr3/ CD4+ OT-II TCR transgenic T cells exhibit defective
activation when transferred into WT hosts (Groom et al., 2012).
To address whether a similar failure might account for the
inability of Cxcr3/ CD8+ T cells to eliminate infected inflamma-
tory monocytes, we generated homozygous Cxcr3/ OT-I TCR
transgenic mice and adoptively transferred 2.5 3 105 WT or
Cxcr3/ OT-I CD8+ T cells into WT recipients. Two days after
infection with SIINFEKL-expressing VV, we removed DLNs
and restimulated liberated cells with synthetic SIINFEKL (Figures
4A and 4B). Whereas restimulation with irrelevant peptide
yielded background IFN-g production, both Cxcr3/ and WT
cells produced high and equivalent amounts of IFN-g in
response to SIINFEKL restimulation (on the basis of mean fluo-
rescent intensity of positive cells; Figure 4B). Similarly, CXCR3
deficiency did not affect OT-I cells’ synthesis of granzyme B
(Figure 4C). Accordingly, Cxcr3/OT-I CD8+ OT-I cells properly
homed to the LN peripheral interfollicular regions (Figure 4D), the
area in which direct priming occurs in the LN after VV infection
(Hickman et al., 2008). Together, these data show that CXCR3
is not required for SIINFEKL-expressing VV-induced activation
of OT-I CD8+ T cells in vivo.
CXCR3 can control T cell homing during both infection and
autoimmunity (reviewed in Groom and Luster, 2011a, 2011b).
Comparing ear-immigrant T cells between WT and Cxcr3/
mice revealed non-statistically significant changes in T cell
recruitment (as a percentage of total cellular recruitment) on
p.i. days 6 and 7 (Figures 4E and 4F). Ear-derived polyclonal
Cxcr3/ CD8+ T cells synthesized IFN-g in response to restim-
ulation with VV-infected cells or VV-derived peptides (Figure 4F)Immunity 42, 524–537, March 17, 2015 ª2015 Elsevier Inc. 527
Figure 3. Cxcr3–/– Mice Have Elevated Numbers of VV-Infected Inflammatory Monocytes
(A) Confocal montages of frozen sections of WT (left) or Cxcr3/ ears on p.i. day 5 (right). VV-infected cells (green), keratin 10 (red), and CD45 (blue) are shown.
Scale bars represent 300 mm.
(B) Confocal image of a Cxcr3/ ear on p.i. day 5. CD11b (white) and VV-infected cells (green) are shown. The scale bar represents 20 mm.
(C) Flow histograms from a dissociated ear on p.i. day 5. Top panels show aWTmouse. Bottom panels show aCxcr3/mouse. The second column of dot plots
(bothWT andCxcr3/mice) are gated on total cells. The third column of dot plots show infected (GFP+) cells. The fourth column of dot plots are gated on infected
cells and show the percentage of infected cells that are inflammatory monocytes (Ly6CGint cells) and neutrophils (Ly6CGhi cells).
(D) Total inflammatory monocytes on p.i. days 5 and 6 in WT (blue) or Cxcr3/ (green) ears.
(E) Time course of infected inflammatory monocytes in WT (blue) or Cxcr3/ (green) ears.
(F) Titer of infectious virus recovered per ear on the indicated p.i. day in WT (blue) or Cxcr3/ (green) mice.
(G) Percentage and number of infected inflammatory monocytes in WT (blue) or Cxcr3/ (green) ears on p.i. day 6. Ab treatment groups (treatment was per-
formed prior to T cell entrance into the ear on p.i. days 4 and 5) are shown on the x axis.
Error bars represent the SEM. Statistics were obtained by unpaired t tests. All experiments were repeated at least three times with n = 2–5 mice/group.
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Figure 4. Cxcr3–/– CD8+ T Cells Activate and Home Normally
(A) Dot plots from LN cells 2 days after infection with VV-NP-S-eGFP. Mice were given 2.53 105 WT or Cxcr3/OT-I CD8+ T cells prior to infection. Gates show
the percentage of IFN-g+ cells after restimulation with the indicated peptide (top).
(B) Percentage (left) and mean fluorescent intensity (MFI, right) of IFN-g+ cells after restimulation. Endogenous CD8+ cells (all non-transferred CD8+ T cells in the
LN) are shown for comparison.
(C) MFI of granzyme B.
(D) Frozen LN sections with VV-infected cells (green), B cells (blue), WT OT-I CD8+ T cells (white), or Cxcr3/ OT-I CD8+ T cells (red) were obtained 8 hr after
infection. CD69 is also stained green to indicate activated cells. Scale bars represent 100 (left) or 20 (right) mm.
(E) Percentage of endogenous CD8+ T cells per ear on p.i. days 6 and 7. Blue bars indicate WT cells, and green lines show Cxcr3/ cells.
(F) Number of IFN-g+ cells per ear in WT (blue) or Cxcr3/ (green) mice on p.i. day 6 (left) or 7 (right).
Error bars represent the SEM. Statistics were obtained by unpaired t tests. All experiments were repeated at least three times with n = 4–6 mice/group.such that numbers of IFN-g+CD8+ T cells were similar on p.i.
days 6 and 7. Cxcr3/ T cell responses were actually enhanced
on p.i. day 6 for B8R (the immunodominant VV determinant in
C57BL/6 mice; Tscharke et al., 2005).On the basis of these findings, we conclude that Cxcr3/
CD8+ T cells exhibit normal activation, tissue homing, and
effector cytokine secretion in response to peripheral VV
infection.Immunity 42, 524–537, March 17, 2015 ª2015 Elsevier Inc. 529
Cxcr3–/– CD8+ T Cells Fail to Efficiently Engage and
Remain in Contact with Virus-Infected Cells in the
Tissue
We next assessed the contribution of CXCR3 to CD8+ T cell
localization and killing of virus-infected cells. Prior to infection,
we co-transferred WT (cyan) and Cxcr3/ (red) OT-I CD8+
T cells into WT mice. On p.i. day 5, we imaged ears infected
with VV-NP-S-eGFP (green; Figure 5). Via MPM, we clearly
visualized Cxcr3/ CD8+ T cells in the dermis (distinguished
by the presence of dermal collagen; Movie S2), consistent with
ex vivo flow cytometric analyses showing Cxcr3/ T cell entry
into the ear. Like WT cells, Cxcr3/ OT-I CD8+ T cells facilely
migrated to surround large, VV-infected keratinocytic foci (Fig-
ure 5A; Movie S3).
Given that CD8+ T cell killing of VV-infected inflammatory
monocytes contributes topoxvirus clearance in the skin (Hickman
et al., 2013), we next assessed the ability ofWT (cyan) orCxcr3/
(red) OT-I cells to locate infected cells (Figure 5B). Both cells
located VV-infected cells (previously identified as inflammatory
monocytes; Hickman et al., 2013) outlying major keratinocytic
lesions (Movie S4). Indeed, we occasionally visualized Cxcr3/
T cells actively pursuing virus-infected cells (Movie S5). Overall,
however, whereas high numbers of WT T cells entered fields of
virus-infected cells, Cxcr3/ T cells hesitated at the perimeter
of heavily infected areas of the tissue (Figure 5C; Movie S6). To
quantitate this phenomenon, we acquired (while blinded to the
presence of WT cells) MPM images of dense areas of infected
monocytes and quantified the percentage (as a function of total
cells in the entire field) of WT or Cxcr3/ OT-I cells that had
entered areas of infection (Figure 5D). AlthoughWT andCxcr3/
T cells were equally distributed outside of infected areas of
the dermis, a higher percentage of WT T cells than of Cxcr3/
T cells penetrated virus-infected areas (Figure 5D).
We next used MPM to simultaneously track WT (cyan) and
Cxcr3/ (red) OT-I CD8+ T cells on p.i. day 5 (Figures 5E–5H).
Over 30-min imaging sessions, Cxcr3/ OT-I CD8+ T cells
clearly moved faster than WT cells (Figures 5E and 5F; Movie
S7). Overlaid tracks of individual cells acquired in the same field
of infected cells likewise revealed greater movement ofCxcr3/
T cells (Figure 5E, left panel) than of WT cells (right panel), a
feature reflected in average cell speeds over the course of mul-
tiple imaging experiments (Figure 5F). On average, WT T cells
were >0.5 mm/min slower than Cxcr3/ T cells (Figure 5F, left
and middle panels). Similar to Cxcr3/ CD4+ T cells interacting
with Ag-pulsed APCs in the LN (Groom et al., 2012), a signifi-
cantly higher proportion of Cxcr3/ CD8+ T cells present in
areas of intense VV infection were highly motile (25.9% versus
16.4%; Figure 5F, right panel).
To determine whether differences in contact with infected
cells could account for motility differences, we imaged WT and
Cxcr3/ OT-I cells interacting with virus-infected cells in the
same field on p.i. day 5; we carefully selected a time period
that was late enough for some Cxcr3/ T cells to penetrate in-
fected areas yet not so late that all of the infected cells had
been lysed. Whereas many WT OT-I cells contacted infected
cells and maintained contact over 30- to 60-min imaging pe-
riods, Cxcr3/ OT-I cells were typically more mobile such that
they moved from one infected cell to another (Figure 5G; Movie
S7). To quantify this, we calculated the percentage of time that a530 Immunity 42, 524–537, March 17, 2015 ª2015 Elsevier Inc.T cell contacted an infected cell during a 1-hr imaging period
(note: we did not include any cells that did not stably contact
an infected cell within the first 15 min of imaging; Figure 5H).
WT T cells remained engaged with virus-infected cells for a
longer period after initiating contact (89.3% ± 2.9% [WT] versus
61.2% ± 4.2% [Cxcr3/] of the imaging period). Likewise,
although both T cell types rapidly scanned virus-infected cells
with which they were engaged, the difference in contact times
was reflected in longer pauses (e.g., the cell’s time with an
instantaneous velocity < 1 mm/min) for WT T cells (63.9% ±
3.5% [WT] versus 36.6% ± 3% [Cxcr3/]; Figure 5H; Figure S4).
Taken together, these data show that relative to WT cells,
Cxcr3/ CD8+ T cells exhibit decreased presence in virus-
infected regions and shorter contacts with infected cells.
Cxcr3–/– CD8+ T Cells Eliminate Virus-Infected Cells
Less Efficiently
To assess the antiviral function ofCxcr3/ versusWTOT-I CD8+
T cells, we transferred 2.53 105 of either cell type into WT mice,
infected them with VV, and analyzed cells for the production of
IFN-g at p.i. day 5.5 (Figures 6A–6D). Although the number of
transferred T cells in tissues was similar in both cases (demon-
strating the proper homing of activated T cells lacking CXCR3;
Figure 6A), direct ex vivo analysis (i.e., without restimulation) re-
vealed that the number of Cxcr3/ OT-I cells producing IFN-g
was lower than that of WT OT-I T cells (Figures 6B and 6C). On a
per cell basis,Cxcr3/ andWTOT-I cells synthesized equivalent
amounts of IFN-g, reinforcing the conclusion that CXCR3 expres-
sion isnot required forCD8+Tcell effector function if the cells have
appropriately engaged virus-infected targets (Figure 6D).
We further assessed the ability of Cxcr3/ OT-I cells to con-
trol virus infection in vivo by using flow cytometry of cell popula-
tions from dissociated ears. We transferred Cxcr3/ or WT OT-I
cells into CD8-deficient animals and analyzed their ability to
eliminate virus-infected cells (Figure 6E). Cxcr3/ OT-I cells
clearly killed fewer infected cells than did WT OT-I cells.
To more systematically examine this phenomenon and pre-
cisely control for the number of T cells present in infected tissue,
we titrated the number of transferred OT-I cells (ranging from
2.5 3 103 to 7.5 3 105 per animal) and enumerated both
T cells and virus-infected cells in each infected ear (Figures
6F–6J). This enabled us to compare pairs of animals with equiv-
alent numbers of T cells in their ears. For each mouse pair, WT
OT-I T cells (blue area) eliminated more infected cells than did
Cxcr3/OT-I cells (green area) (Figure 6F). Over the entire range
of adoptively transferred T cells used in Figure 6F, an almost
identical number of either WT orCxcr3/OT-I cells was present
per ear (Figure 6G). Averaging the paired data revealed that WT
cells were 4-fold more efficient at eliminating virus-infected cells
(Figures 6H and 6I). Finally, WT OT-I cells significantly reduced
viral titers when present in numbers equivocal to those of
Cxcr3/ T cells (Figure 6J).
These data strongly indicate that Cxcr3/ OT-I cells have a
compromised ability to eliminate VV-infected cells.
WT CD8+ T Cells Control Enhanced VV Infection of
Cxcr3–/– Mice
Although our findings clearly point to an important function
for CXCR3 on T cells during the clearance of virus-infected
Figure 5. Cxcr3–/– CD8+ T Cells Have Reduced Entry into Areas of Infection and Decrease Contact with Virus-Infected Cells
(A) MPM images of skin with VV-infected cells (green), dermis (blue), and WT (cyan) or Cxcr3/ (red) OT-I CD8+ T cells were taken on p.i. day 5. Note that
autofluorescent hairs also appear cyan. Scale bars represent 100 mm.
(B) MPM images from an area with many infected inflammatory monocytes (green). Scale bars represent 50 (left) or 20 (right) mm.
(C) MPM images showing distribution of WT (cyan) orCxcr3/ (red) OT-I CD8+ T cells within a densely infected area (indicated by shading). For clarity, each color
is shown independently. Scale bars represent 50 mm.
(D) Percentage of WT (blue) or Cxcr3/ (green) OT-I CD8+ T cells within densely infected areas. Dots represent individual microscopic fields. Line represents the
mean.
(E) Overlaid tracks of T cells from the same field during a 30-min imaging period. Tracks are color coded from slow (blue) to fast (red).
(F) The left panel shows average mean speeds of WT (blue) or Cxcr3/ (green) OT-I CD8+ T cells from the same field in an imaging session (statistics fromMann
Whitney test). In the middle panel, WT orCxcr3/OT-I T cells in the same field are connected with a line (statistics fromWilcoxon test). The right panel shows the
percentage of cells moving >2 SDs from the mean speed of WT OT-I CD8+ T cells; lines indicate pairs in the same imaging field (statistics from Wilcoxon test).
(G) Still-frame MPM images of WT (cyan) or Cxcr3/ (red) OT-I T cells over 30 min. A WT cell (cyan circle) and a Cxcr3/ cell (red circle) are followed over time.
Scale bars represent 20 mm.
(H) The left panel shows the percentage of time during which WT (blue) and Cxcr3/ (green) cells are contacting infected cells during a 1-hr imaging period. The
right panel shows the percentage of time during which WT and Cxcr3/ cells paused on infected cells. Results were combined from two individual experiments
and repeated twice.
Time is shown in min. Error bars represent the SEM. All experiments except those in (H) were repeated at least three times with n = 4–6 mice/group. See also
Figure S4 and Movies S2, S3, S4, S5, S6, and S7.
Immunity 42, 524–537, March 17, 2015 ª2015 Elsevier Inc. 531
Figure 6. Cxcr3–/– CD8+ T Cells Do Not Kill Infected Cells as Efficiently as WT CD8+ T Cells Do
(A) Number of WT or Cxcr3/ OT-I CD8+ T cells on p.i. day 5 after adoptive transfer into WT animals. Dots represent individual ears.
(B) Dot plots gated on the percentage of transferred T cells (dsRed+, top panels) or on IFN-g+ T cells (bottom panels). WT OT-I cells are on the left, and Cxcr3/
OT-I cells are on the right.
(C) Number of IFN-g+ cells per ear on p.i. day 5.
(D) MFI of IFN-g signal from the IFN-g+ population of transferred cells.
(E) Percentage of transferred cells (top panels) recovered inCd8/ ears after transfer of 2.53 105 OT-I cells. No transfer (left panels),WTOT-I cell transfer (middle
panels), and Cxcr3/ OT-I transfer (right panels) are shown.
(F) Number of infected cells inCd8/ ears and titrated numbers (from 2.53 103 to 7.53 105) of transferredWT (blue) orCxcr3/ T (green) cells. The x axis shows
pairs of Cd8/ mice in which equivalent numbers of transferred OT-I T cells were recovered.
(G) Number of T cells recovered in Cd8/ mice in the experiment shown in (F).
(H) Number of infected monocytes per ear from the experiment in (F).
(I) Ratios frommice in (F). The left bar shows the number of recovered transferredCxcr3/OT-I cells divided by the number of recoveredWTOT-I cells. The right
bar shows the number of infected cells recovered in animals receiving Cxcr3/OT-I cells divided by the number of infected cells recovered in animals receiving
WT OT-I cells.
(J) Virus titer per ear from the experiment in (F).
Statistics were obtained by a two-tailed Student’s unpaired t test (A–C) or a two-tailed paired t test (F). Error bars represent the SEM. Experiments were performed
three times with n = 3–4 mice/group (A–C) or five times with n = 2–3 mice/group (F and G).
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Figure 7. Transfer of WT OT-I CD8+ T Cells into Cxcr3–/– Animals Restores Viral Control
(A) Dot plots from Cxcr3/ mice with no T cell transfer (left) or with 2.5 3 105 WT (middle) or Cxcr3/ (right) OT-I T cells on p.i. day 5.
(B) Number of adoptively transferred WT or Cxcr3/ OT-I CD8+ T cells recovered per ear in Cxcr3/ animals on p.i. day 5.
(C) Number of virus-infected cells per ear in Cxcr3/ animals adoptively transferred with WT or Cxcr3/ OT-I CD8+ T cells.
(D) Viral titers from (A).
(E) Confocal montage images ofCxcr3/ ears 5 days after infection with VV (green). Mice were transferred with either WT (left) orCxcr3/ (right) OT-I T cells (red)
before infection. CD45+ cells are shown in blue. For clarity, only the green channel is shown in the bottom panels. Scale bars represent 300 mm.
Statistics were obtained by an unpaired two-tailed t test. Error bars represent the SEM.tissues, it is possible that CXCR3 expression on other cells
(innate leukocytes, keratinocytes, etc.) contributes to virus
clearance under normal conditions. To address this important
issue, we transferred WT or Cxcr3/ OT-I cells into Cxcr3/
mice prior to infection with VV-NP-S-GFP and examined in-
fected ears on p.i. day 5. Both WT and Cxcr3/ OT-I cells effi-
ciently homed to infected Cxcr3/ ears (dsRed+ cells; Figures
7A and7B). Despite the fact that WT and Cxcr3/ OT-I cells
had nearly equivalent entry, WT OT-I cells had far fewer in-fected inflammatory monocytes reflected in diminished viral ti-
ters (Figures 7C and 7D). Confocal tile-scan imaging of frozen
sections of ears confirmed the absence of large numbers of
VV-infected inflammatory monocytes in Cxcr3/ mice that
received WT T cells (Figure 7E), which now resembled infected
tissue in WT mice (see Figure 3A). Conversely, confocal tile
scans from Cxcr3/ animals that received Cxcr3/ OT-I cells
more closely mirrored Cxcr3/ animals without T cell transfer
(see Figure 3A).Immunity 42, 524–537, March 17, 2015 ª2015 Elsevier Inc. 533
On the basis of these data, we conclude that the positive
effects of CXCR3 expression on CD8+ T cell anti-viral activity
can be largely, if not completely, ascribed to its function on
CD8+ T cells themselves.
DISCUSSION
The chemokine receptor CXCR3 and its ligands play important
roles in antiviral immunity. Effector CD8+ T cells upregulate
CXCR3 (a transcriptional target of t-bet) after infection with a va-
riety of viruses (Taqueti et al., 2006). As a G-protein-coupled
chemotactic receptor, CXCR3 affects tissue recruitment of anti-
viral CD8+ T cells (for examples, see Hokeness et al., 2007; Klein
et al., 2005; Lee et al., 2005; Slu¨tter et al., 2013). Additionally,
CXCR3 signaling can modify antiviral effector CD8+ T cell differ-
entiation, given that the absence of CXCR3 in murine infections
with lymphocytic choriomeningitis virus (LCMV), influenza A virus
(IAV), or VV results in increased memory CD8+ T cells at the
expense of short-lived effector cells (Hu et al., 2011; Kohlmeier
et al., 2011; Kurachi et al., 2011). During secondary viral infec-
tions, CXCR3 expression by LN memory effector CD8+ T cells
is needed for T cell trafficking to infected peripheral tissues (Kas-
tenmu¨ller et al., 2013; Sung et al., 2012). Additionally, CXCR3
expression allows circulating effector T cells to home to inflamed
LNs (Guarda et al., 2007). This is no doubt a partial list of the
functions of CXCR3 expression on antiviral CD8+ T cells.
The impact of CXCR3 deficiency on viral replication and path-
ogenesis in mice varies with the virus studied, although here too,
much remains to be learned.Cxcr3 deficiency increases suscep-
tibility to genital herpes simplex virus type 2 (Thapa and Carr,
2009) and intracerebral dengue virus (Ip and Liao, 2010). Inter-
estingly, protection in each of these models is mediated inde-
pendently of CXCR3-dependent leukocyte recruitment. CXCR3
deficiency does not appear to alter the outcome of mouse infec-
tion with either LCMV (Mahalingam et al., 1999) or herpes sim-
plex virus type 1 (Wickham et al., 2005). Lee et al. (2005) reported
no effect on morbidity other than delayed viral clearance in
Cxcr3/ mice infected with murine gammaherpesvirus 68;
they attributed this to delayed T cell recruitment, although they
also observed deficient Cxcr3/ T cell lysis of target cells. Like-
wise, we saw no overt changes in morbidity after epicutaneous
VV infection; however, Cxcr3 deficiency interfered with viral
clearance at intermediate times of infection (days 5–7). These
data strongly imply that in studies limited to mortality or weight
loss as a read-out, additional effects of Cxcr3 deletion in other
virus models could be missed.
Here, we report that CXCR3 can affect not only T cell migration
into virus-infected or inflamed tissue but also migration within a
tissue as T cells locate virus-infected targets for killing. Although
this decreased ability of Cxcr3/ CD8+ T cells to effectively
locate and eliminate infected cells clearly contributes to exacer-
bated VV infection in Cxcr3/ mice, it is likely that additional
factors also enhance infection in these animals. Prior to the entry
of primed T cells into the ear, Cxcr3/ animals exhibit elevated
numbers of infected cells, indicating enhanced early virus repli-
cation and/or dissemination independent of T cell control. This
suggests a possible role for CXCR3 in innate immune control
of early VV replication (CXCR3 is expressed onmonocytes, plas-
macytoid DCs, and NK cells; Koch et al., 2009). Additionally,534 Immunity 42, 524–537, March 17, 2015 ª2015 Elsevier Inc.Cxcr3/ mice exhibit delayed dermal wound healing in non-
infectious models (Yates et al., 2008; Yates et al., 2007), which
could potentially contribute to early VV spread. Whatever the
case, the enhanced VV infection we found in Cxcr3/ mice
was controlled by CD8+ T cells, and VV was cleared even in
the absence of Cxcr3, although this was delayed in comparison
to clearance in WT mice.
In the current study, we did not determine all of the cell types
synthesizing CXCR3 ligand(s) at different times during infection,
partly as a result of concern about the sensitivity of immunohis-
tochemical staining for CXCL9 and CXCL10 (Groom and Luster,
2011b). It will be important to better characterize producing
cells in future studies. For this purpose, recently described
REX3mice, which fluorescently reportCxcl9 andCxcl10 expres-
sion with different fluorophores (Groom et al., 2012), should be
quite useful. At present, however, no system is without additional
interpretational complications, given that non-chemokine-
producing cells can bind and display functional CXCL9 and
CXCL10, which would not be indicated by a fluorescent reporter
system (Groom and Luster, 2011b). Importantly, CXCL9 and
CXCL10 can be induced by different stimuli and therefore
expressed by different repertoires of cells, which can then alter
their effects on disease (Groom and Luster, 2011a, 2011b).
Further complicating matters, the timing of Cxcl9 and Cxcl10
mRNA expression is not identical in VV-infected skin, given
that Cxcl9 mRNA peaks approximately 2 days later than
Cxcl10mRNA. Thus, it is likely that different populations of cells
in the skin (perhaps including non-hematopoietic cellular skin
components; Huen and Wells, 2012) produce these two
CXCR3 ligands, especially at later times in infection.
Despite these unknowns, the dramatic upregulation of Cxcl9
and Cxcl10 mRNA in infected inflammatory monocytes,
confirmed by in situ immunohistochemical staining of frozen tis-
sue, suggests that these cells are a major source of CXCR3
ligands. VV-infected inflammatory monocytes largely localize in
densely packed dermal areas adjacent to foci of virus replication
in keratinocytes (Hickman et al., 2013). Whereas anatomically
confined infection most likely results from local virus spread in
the tissue, the presence of numerous targets in close proximity
greatly enhances the ability of T cells to find and clear infection.
Interestingly, we did not observe Levy walk behavior as T cells
were hunting virus-infected cells (Harris et al., 2012), most likely
because of the heavy density of ‘‘prey’’ (rather than sparse distri-
bution) in the skin. Our data further suggest that infected cells
produce a localized gradient of CXCR3 ligands that T cells utilize
for entrance into areas of infection. Future studies are required
to determine the contribution of serial killing by individual cells
versus recruitment of greater numbers of T cells to CXCR3-
dependent virus clearance. In the latter case, this would most
likely increase the importance of chemokine guidance into heavi-
ly infected areas of the tissue.
The interactions and functions mediated by CXCR3 in the tis-
sue are clearly diverse and appropriately complex. Despite this,
it might yet be possible to manipulate the system for pragmatic
applications. Here, we have shown that CXCR3 maximizes VV
clearance in peripheral tissues independently of its influence
on tissue immigration, which could potentially be exploited dur-
ing rational vaccine design. Intriguingly, neutralization of inter-
leukin-12 shortly after IAV immunization boosts the number of
CXCR3-expressing memory CD8+ T cells, which then afford su-
perior protection against subsequent IAV challenge (Slu¨tter et al.,
2013). Thus, strategies to increase CXCR3-expressing CD8+
T cells are already in place and might be applied during vaccina-
tion to enhance viral clearance by maximizing T cell killing.
EXPERIMENTAL PROCEDURES
Mice
Specific pathogen-free C57BL/6, B6(Cg)-Tyrc-2J/J, STOCK Tg(CAG-
DsRed*MST)1Nagy/J, Cd8/ (stock no. 2665), and Cxcr3/ (stock no.
5796) mice were obtained from The Jackson Laboratory or from Taconic
Farms. STOCK Tg(CAG-DsRed*MST)1Nagy/J mice were crossed to OT-I
TCR transgenic mice (NIAID Intramural Research Repository) and bred for ho-
mozygosity for the creation of DsRed OT-I mice. DsRed OT-I mice were
crossed with Cxcr3/ mice for the generation of homozygous female
Cxcr3/ DsRed OT-I mice. OT-I TCR transgenic mice were also crossed
with CFP-expressing mice (B6.129(ICR)-Tg(CAG-ECFP)CK6Nagy/J, stock
no. 4218, The Jackson Laboratory) for the creation of WT OT-I CFP mice.
6- to 16-week-old female mice were used in all experiments. All mice were
housed under specific pathogen-free conditions (including murine norovirus,
mouse parvovirus, and mouse hepatitis virus) and maintained on standard ro-
dent chow andwater supplied ad libidum. All animal studies were approved by
and performed in accordance with the Animal Care and Use Committee of the
National Institute of Allergy and Infectious Diseases.
Viruses and Infections
Mice were anesthetized and infected epicutaneously in the ear by five gentle
pokes with a bifurcated needle dipped in VV (stock titer 1 3 108 pfu/ml), as
previously described (Hickman et al., 2013). VV-NP-S-eGFP contains the
CD8+ T cell determinant SIINFEKL, recognized by OT-I CD8+ T cells; VV-NP-
eGFP is an identical virus lacking the SIINFEKL determinant. Viruseswere con-
structed as TK viruses in which the recombinant insert was expressed by an
early-late vaccinia promoter. Fluorescence expression is an indication of infec-
tion rather than the amount of released infectious virions.
T Cell Transfers
CD8+ T cells were purified by negative selection with the use of AutoMACS
(Miltenyi Biotec). Cells were 90%–95% pure by flow cytometry. A total of
2.53 105 (unless dose is otherwise indicated) OT-I cells were transferred intra-
venously prior to infection. For some multiphoton imaging experiments, WT
CFP-expressing OT-I cells and Cxcr3/ dsRed-expressing OT-I cells were
co-injected.
Flow Cytometric Analyses
Single-cell suspensions of ears were prepared by collagenase digestion (type
I, Worthington Biochemicals) for 1 hr at 37C prior to filtration through 70-mm
nylon cell strainers. Cells were stained with the following antibodies: CD45
(clone 30-F11), CD8 (clone 53-6.7), CD11b (clone M1/70), and Ly6CG (clone
Gr-1) (eBioscience). OT-I cells were identified on the basis of CFP or dsRed
expression. For intracellular staining for IFN-g production, brefeldin A
(10 mg/ml, Sigma-Aldrich) was added during collagenase digestion, and cells
were incubated 2 hr in RPMI containing BFA. Cells were stained, fixed
for 20 min with 1% paraformaldehyde, washed, and then stained with anti-
IFN-g (clone XMG1.2) in 0.5% saponin overnight at 4C. Cells were analyzed
on an LSR II flow cytometer (BD Biosciences), and data were analyzed with
FlowJo (Tree Star).
Viral Titering via Plaque Assay
Ears were removed at various p.i. times, and collagenase was digested for 1 hr
at 37C and disrupted by vigorous pipetting. This suspension was frozen and
thawed three times, sonicated three times, serially diluted, and plated on TK
cells. Cells were incubated for 2 days before plaques were counted.
Ab Depletion
For Ab-based depletions, 0.5 mg of either anti-CD8 Ab (clone 53-6.7) or anti-
NK cell Ab (clone NK1.1) was given intraperitoneally daily beginning on p.i. day4 (just prior to T cell entry into infected skin), as described in Hickman et al.
(2013). Ears were analyzed on p.i. days 5 and 6.
qPCR Arrays
Ears were removed, and the dorsal and ventral halves were separated and
immediately deposited in Trizol (Sigma). Ears were chopped into small pieces
and then homogenized and passed through a 20-gauge needle. RNA was iso-
lated according to the manufacturer’s instructions and then purified with the
QIAGEN RNAEasy Mini Kit. On-column DNase digestion was performed prior
to RNA elution. cDNAs were made with the RT2 First Strand Kit (QIAGEN),
which started with 2.5 mg of RNA per sample. cDNAs were loaded onto the
Inflammatory Cytokines and Receptors qPCR array (PAMM-011Z, QIAGEN),
and RT-PCR data were acquired on a RealPlex RT-PCRmachine (Eppendorf).
Rox was used as a loading control. Expression changes of genes of interest
were calculated against five standard housekeeping genes included on the
same plate with the use of the manufacturer’s data-analysis software based
upon DDCT (SABiosciences, now QIAGEN).
Statistics
Statistical significances were calculated by GraphPad (Prism) with the indi-
cated tests. All t tests performed were two tailed.
Confocal Microscopy of Frozen Sections
Ears were removed at the indicated times, fixed overnight in periodate-lysine-
paraformaldehyde buffer, and placed in 30% sucrose and PBS for 24 hr before
being embedding in optimal-cutting-temperature medium (Electron Micro-
scopy Sciences) and frozen in dry-ice-cooled isopentane. Twenty-micron
sections were cut on a Leica cryostat (Leica Microsystems). Sections were
blocked with 5% goat, donkey, or rabbit serum and then stained with one or
more of the following: CD11b (clone M1/70), B220 (clone RA3-6B2), CD45
(clone 30-F11), CXCL9 (clone MIG-2F5.5, Biolegend), keratin 10 (rabbit poly-
clonal, Abcam), and/or CD69 (polyclonal goat, R&D Systems).
Intravital MPM Imaging
MPM imaging was performed as described previously (Hickman et al., 2013;
Hickman et al., 2008). In brief, images were acquired on an upright Leica
SP5 confocal microscope (Leica Microsystems) equipped with two Mai Tai
Ti:Sapphire lasers (Spectra Physics). Ears were immobilized and bathed in
warm saline. Images were acquired with a 203 dipping objective (numerical
aperture = 1.00). Images were obtained at 900 nm for eGFP-collagen-dsRed
imaging. Imaging of CFP-collagen-GFP-sRed was performed in sequential
mode at 900 and 800 nm (for CFP excitation). Emitted fluorescence was
collected with a four-channel non-descanned detector. Wavelength separa-
tion was accomplished with a 495-nm dichroic mirror followed by emission
filters of 460/50 nm and 525/50 nm. The red channel was collected by a detec-
tor after it passed through a 560-nm dichroic with a 610/60 bandpass emission
filter. For most movies (e.g., when time was critical), images were acquired
with 23 zoom and a 3-mm z step for a total depth of 45 mm every 30 s. During
sequential mode, this time interval was extended to 1–3 min between series
(to allow for switching lasers).
MPM Analysis
Maximum intensity projections were processed from z stacks with Imaris
(Bitplane). For tracking cellular movement, images were processed with a
Gaussian filter, and then tracks were calculated with the ‘‘spot’’ function. Over-
laid tracks were generated with Imaris XT function ‘‘translate tracks’’ and were
pseudocolored according to the average speed of the cell creating the track.
Average speeds were calculated with the following parameters: autoregres-
sive motion, gapclose 1, 7.5-mm object diameter, and 20-mm maximum
distance. Created tracks were analyzed individually by hand for erroneous
connections.
For analysis of the percentage of T cells that entered virus-infected areas,
microscopic fields were selected on the basis of the presence of high densities
of GFP+ non-keratinocytic infected cells. Fields were collected so that approx-
imately 50%–75% of the field contained infected cells, and this process was
blinded to the presence of WT T cells. WT and Cxcr3/ T cells were enumer-
ated with spot-detection software (Imaris) inside and outside the area of in-
fected cells. The percentage of WT or Cxcr3/ CD8+ T cells within the areaImmunity 42, 524–537, March 17, 2015 ª2015 Elsevier Inc. 535
of virus-infected cells (as a function of the total number of T cells present in
the image) was then calculated. Data were plotted with GraphPad Software
(Prism).
For analysis of contact timeswith infected cells, it was critical to wait until p.i.
days 5.5–6.0, when Cxcr3/ T cells had time to enter areas of viral infection
(but infected cells had not yet been lysed). One-hour movies were collected
with a 4-mmz step at 23magnification. Trackswere createdmanually because
the large number of cells present resulted in erroneous classifications by auto-
mated tracking. Contact time per infected cell was manually assigned for 15–
30 cells per independent experiment and reported as a percentage of time in
contact during the total 1-hr imaging period. The number of ‘‘pause’’ steps was
calculated automatically with the ImarisXT function ‘‘calculate track length’’
with an input pausing value of 1 mm/min.
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